drugset / Trial / NCT03195946

Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes

NCT03195946

Phase 1 Completed 24 enrolled H. Lundbeck A/S
NaSingle-groupOpen-labelTreatment

Summary

This study will help determine which types of drugs that may interact with Lu AF35700

Timeline

Start
2017-06-16
Primary completion
2018-01-03
Completion
2018-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 200 mg Oral
Subject Dextromethorphan Unknown 30 mg Oral
Subject Lu AF35700 Unknown 10 mg Oral
Subject Midazolam Small molecule 0.025 mg/kg Oral
Subject Midazolam Small molecule 4 mg Oral
Subject Omeprazole Other / unclassified 40 mg Oral